Jiaheng Xie
ORCID: 0000-0002-4992-498XAlso affiliated with AbbVie (United States), Xiangya Hospital Central South University, Nanjing Medical University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 4 papers. Top paper: “Mast cell marker gene signature: prognosis and immunotherapy response prediction in lung adenocarcinoma through integrated scRNA-seq and bulk RNA-seq”.
Jianlan Liu, Shengbin Pei, Dan Wu, Jiaheng Xie, Jinhui Liu +2 more
Min Zhang, Jiaheng Xie, Guangyu Yang, Anil Sapru, Carolyn S. Calfee +5 more
Dan Wu, Pengpeng Zhang, Songyun Zhao, Min Qi, Jiaheng Xie
Zihao Li, Kaibo Liu, Gaoyi Wang, Quanqiang Wang, Hua Yu +7 more